We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$521M
AUM Growth
+$64M
Cap. Flow
+$31.7M
Cap. Flow %
6.08%
Top 10 Hldgs %
25.71%
Holding
256
New
50
Increased
81
Reduced
62
Closed
52

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$14.6M
2
MET icon
MetLife
MET
+$9.19M
3
WBA
Walgreens Boots Alliance
WBA
+$9.05M
4
C icon
Citigroup
C
+$8.2M
5
TGT icon
Target
TGT
+$7.95M

Sector Composition

Rank Sector Weight
1 Technology 17.67%
2 Financials 16%
3 Healthcare 11.72%
4 Industrials 8.96%
5 Consumer Discretionary 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCOV
151
DELISTED
Brightcove, Inc.
BCOV
$341K 0.07%
24,125
+150
+0.6% +$2.1K
TGI
152
DELISTED
Triumph Group
TGI
$321K 0.06%
4,217
-50
-1% -$3.63K
UNIS
153
DELISTED
Unilife Corporation
UNIS
$320K 0.06%
7,266
+446
+7% +$16.3K
SJM icon
154
J.M. Smucker
SJM
$12.8B
$318K 0.06%
+3,069
New +$325K
EXXI
155
DELISTED
ENERGY XXI LTD COM SHS
EXXI
$318K 0.06%
11,739
-2,902
-20% -$83.2K
TAX
156
DELISTED
Liberty Tax, Inc. Class A
TAX
$315K 0.06%
12,948
+1,225
+10% +$26.3K
SLCA
157
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$312K 0.06%
9,158
-2,979
-25% -$97.8K
CERS icon
158
Cerus
CERS
$474M
$309K 0.06%
47,850
-200
-0.4% -$1.26K
WTSL
159
DELISTED
WET SEAL INC CL-A
WTSL
$306K 0.06%
112,074
-1,200
-1% -$3.84K
NAVB
160
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$295K 0.06%
+7,126
New +$279K
SN
161
DELISTED
Sanchez Energy Corporation
SN
$288K 0.06%
+11,731
New +$312K
EBIX
162
DELISTED
Ebix Inc
EBIX
$281K 0.05%
19,118
-100
-0.5% -$1.28K
TGTX icon
163
TG Therapeutics
TGTX
$7.62B
$277K 0.05%
71,105
+38,963
+121% +$157K
MTOR
164
DELISTED
MERITOR, Inc.
MTOR
$271K 0.05%
25,941
-100
-0.4% -$781
GSM icon
165
FerroAtlántica
GSM
$839M
$267K 0.05%
14,852
-100
-0.7% -$1.72K
SNI
166
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$265K 0.05%
+3,061
New +$240K
CB
167
DELISTED
CHUBB CORPORATION
CB
$265K 0.05%
2,745
CTG
168
DELISTED
Computer Task Group, Inc.
CTG
$258K 0.05%
13,702
-100
-0.7% -$1.79K
BAX icon
169
Baxter International
BAX
$14.2B
$256K 0.05%
+6,769
New +$246K
MPO
170
DELISTED
MIDSTATES PETE CO INC COM NEW
MPO
$244K 0.05%
3,680
+40
+1% +$2.32K
CCXI
171
DELISTED
ChemoCentryx, Inc.
CCXI
$239K 0.05%
41,355
+3,800
+10% +$19.6K
DE icon
172
Deere & Co
DE
$168B
$237K 0.05%
2,600
SUNE
173
DELISTED
SUNEDISON, INC COM
SUNE
$237K 0.05%
18,155
-73,861
-80% -$833K
FCSC
174
DELISTED
Fibrocell Science Inc.
FCSC
$236K 0.05%
+3,867
New +$225K
CYTK icon
175
Cytokinetics
CYTK
$10.4B
$233K 0.04%
+35,774
New +$235K

Similar funds

Stoneridge Investment Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Stoneridge Investment Partners held 256 positions worth $521M, up 14% from $457M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Stoneridge Investment Partners deployed $31.7M of net new capital in Q4 2013, opening 50 new positions and adding to 81 existing holdings. Its largest new stake was Mondelez International: 285,413 shares worth $10.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Target, an estimated $7.95M trimmed.

  • Stoneridge Investment Partners's largest Q4 2013 buy was Mondelez International: 285,413 shares worth $10.1M.
  • Stoneridge Investment Partners added most to Twenty-First Century Fox, Inc. Class A in Q4 2013, an estimated $9.61M increase.
  • Stoneridge Investment Partners's biggest Q4 2013 reduction was Target, cutting an estimated $7.95M.
  • Stoneridge Investment Partners fully exited AbbVie in Q4 2013, selling an estimated $14.6M.
  • Stoneridge Investment Partners's ten largest holdings make up 26% of its $521M portfolio in Q4 2013.
  • Stoneridge Investment Partners opened 50 new positions and closed 52 in Q4 2013.
  • Stoneridge Investment Partners's portfolio value rose 14% quarter-over-quarter to $521M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2013, filed 14 Jan 2014.